Toboxy

Toboxy contains moxifloxacin (a broad-spectrum antibiotic that belongs to the class of drugs known as fluoroquinolones). It works by inhibiting enzymes (topoisomerase IV and DNA gyrase) in bacteria which prevents the DNA replication, transcription, repair, and recombination that is essential for the survival of the susceptible organism. In this way Toboxy is effective against a wide range of both gram negative and gram positive bacteria such as Enterococcus faecalis, Streptococcus pneumoniae, Streptococcus pyogenes, Escherichia coli, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, and Moraxella catarrhalis.

Yes, Toboxy can be taken with paracetamol. No harmful drug interaction has been reported between them. It is safe to take Toboxy along with paracetamol if it does not exceed the recommended dosage.

No, Toboxy does not cause weight gain. It has not been reported by the patients who are taking. However, if notice any unusual weight gain after taking this drug and you are in doubt that Toboxy is causing weight gain then discuss it with your doctor.

The dosage of this drug may vary depending on the type of infection and severity of the infection. Usually, oral Toboxy is recommended to be taken once daily or as advised by your doctor. It can be taken with or without the food because food does not affect the absorption of this drug. Precautions must be taken in patients with rheumatoid arthritis, heart diseases, diabetes mellitus, and improper liver or kidney function.

Yes, Toboxy is helpful in treating pneumonia. It is used in the treatment of commnunity acquired pneumonia caused by bacteria Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae, and Chlamydophilia pneumoniae. The duration of treatment depends on infection severity and patients medical condition but it is generally given for 7-14 days.